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ABSTRACT
Osteomyelitis is abone-related infectious desease which is difficult lo treat, because the antibiotic reaches the largei is lower than the MIC andbacteria can > be
eradicated. This condition can cause the bacteria become resistant. To solve this problem, we can use load antibiotics as BHiG(ELENA) pellets implant, which
can release gentamicin (GEN) continuously for more than a day with a concentration gieater than MIC. BHAG(ELENA) pellet that have made contain BHA :
GEL = 20: 2 (dry sltMe), GEN 10% and cross-linking with glutaraldehyde (G.i)0,5%, cylindrical weigh 100 mg: 4mm indiameter and3.2 mm thick. The release
of GEN from BHAG(ELENA) pellet were tested in vitro, by soaking the pellet in phosphate buffer saline pH 7.4 at temperature 370C The sample were sampled
every day mail 28 days. Then, the sample were tested by agar diffusion method that contain Staphylococcus aureus. Results showed that inhibition zone diameter
greater than MIC GEN to S. aureus. Within 28 days, the release of GEN provide atotal actrvily 99.24%, it showedthat after 28 days, the pellets are still actively
inhibit the bacterial growth. Furthermore, required lo be tested in animal study (in vivo) withadefect in the femoral bone then filled with BHAG(ELENA) pellets
as drug delivery system iff GEN and bone fillers.
Keywords: agar diffusion method Bovine Hydroxyapatite (BHA), gelatin (GEL), gentamicin (GEN), glutaraldehyde (GA) and drug delivery system (DDS).
INTRODUCTION
Osteomyelitis (OM) is a progressive infection of the bone
marrow and cortex that resulting an inflammation and bone
destruction (Nadeem el al.,2010). If this condition is not han¬
dled properly, it can cause tissue damage, functional organ
damage and also death of bone with a high degree of morbidity
(McNally el al,2010). Osteomyelitis can occur due to trauma
at the bone open fracture, closed fracture, joint replacement,
postoperative bone, and infected diabetes mellitus (DM).The
incidence of OM due to spinal surgery about 1-5% at the pa¬
tients with closed fracture; open fractureat the I-III level about
3-50% and 5% of implant use (Suratun el al., 2006). Patients
who suffered an open fracture can be OM about 3-25%, where¬
as the diabetic patients with foot ulcers approximately 15% (Sia
et al., 2006).
Bone is one of body part that has hard structure. Because
of this condition, not all antibiotics can penetrate and bone
trauma causes devascularisation so the antibiotic in the target
has smaller concentration than MIC. It will become the anti¬
biotics can not eradicate of bacteria, so this bacteria become
resistant. Antibiotics can penetrate biofllms of bacteria colo¬
nies OM when the concentrations up to 10 times than the MIC
(El-Ghannam et al., 2005). While, the bacterial resistance to
the antibiotics can occur due to improper use of antibiotic as
too short and the doses are too low (Borhan, 2013).
On the use of parenteral and oral antibiotics, to obtain a
sufficient dose to OM therapy needed in high dose and long
term. Thus, the antibiotics can penetrate the biofllm of bacte¬
ria and bacterial colonies can be eradicated with 10 times MIC
(El-Ghannam et al., 2005). However, it will cause some prob¬
lems include toxicity to the patient; less of compliance and will
require a long residence time in the hospital that can harm the
patient. One of alternative to solve this problem by using local
antibiotic with BHAG (ELENA) pellet implant.
Gentamicin is one of antibiotics that has a broad-spectrum
so that capable to control the growth of Gram positive and
Gram negative bacteria, water soluble and resistant at body
temperature for a long time. While Staphylococcus aureus is
one of Gram positive bacteria that cause nosocomial infec¬
tion in many hospitals, especially in the orthopaedi surgical
(Jamel, 2011). The BHAG (ELENA) pellet made from bovine
hydroxyapatite (BHA) is an of inorganic component of bone
and gelatin (GEL) is an organic component of bone as drug
delivery system (DDS) and Gentamicin (GEN) as a preventive
or therapeutic antibiotics bone infection that has cross-linked
with ghitaraldehyde (GA) to delay the gentamicin release.
The cross-linking processed of BHA-GEL as drug delivery
system with gentamicin (GEN) was done with the aim to form¬
ing a covalent bond between GEL and GEN both, of them us¬
ing glutaraldehyde (GA) as a cross-link agent (Ginalska et al.,
2005) with a stationary phase of PET, whereas BHA that used
in this study is biocompatible as silence and wrapped by GEL.
The formation of covalent bonds between GEL-GA-GEN
lead BHAG(ELENA) pellet is not easily destroyed and will
continuously release GEN for a long time with concentration
greater than minimum inhibitory concentration (MIC) of
Staphylococcus aureus (0.4 ppm).
The aim, of this study to make BHAG(ELENA) pellet for¬
mula that can eradicate the growth of Staphylococcus aureus in
a period of 28 days, because the antibiotics for a bone infection
is usually administered for 4 to 6 weeks. Test release of GEN
from BHAG(ELENA) pellets performed by soaking the pellets
in phosphate buffered saline pH 7.4 and temperature 370C and
were sampled every day. The sampling results were tested by
using agar diffusion method with the Staphylococcus aureus
bacteria.
MATERIAL AND METHOD
Material
BHAG(ELENA) pellet madefrom 20 gr bovine hydroxyapa¬
tite powder (Dr Soetomo Hospital Tissue Bank Surabaya), 10
ml of gelatin 20 % (Rousselot Guangdong Chines), gentamicin
10 % (Arshine Technology CO, Limited Wanchai China) then
make granules, then perfomed the cross-linking reaction by
immersing the granules in 0,5% glutaraldehyde (E.Merck). A
total of 100 mg of dried granul were made pellets and were
pressed 3 ton, in order to obtain a cylindrical pellets with 4,0
mm in diameter and 3,2 mm thick.
The Release of GEN from BHAG(ELENA) (modification
of Stallmann et al,2006)
The release testing by immersing the pellets in 2 ml of phos-
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phate buffer saline (PBS). The sample were sampled at 30, 90,
180 minutes and every 24 hour for 21 days and 28 days for
about 0.5 ml. the sample were stored at -200C temperature un¬
til analysis. The analyzed of gentamicin concentration by using
agar diffusion method with Staphylococcus aureus bacteria.
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iAgar diffusion method, modified of FJ-Ghannam et at, 2005Antibacterial activities test with agar diffusion method.
One oose Staphylococcus aureus (ATCC 25923) 5.106 colony-
forming units/ml (cfo/ml) from primary culture were inocu¬
lated on slant agar medium. The tubes were incubated at 370C
for 24 hour. Then added 15 ml of saline sterile solution and Fjgure , curve of concentnition GEN (ppm) „fob**.A«.
shaken until all the culture regardless from the medium. The (mm)
bacterial suspensions were measured optical density (OD) at
580 nm, until 25% transmission.
For the antibiotic activity assay, as 6 test tubes of eachlO ml
antibiotic medium were cooled at 45 - 500C and poured into a 6
petri dish (second antibiotic medium) an allowed to solidify. A
total of 5 pL cultures of Staphylococcus aureus (ATCC 25923)
were suspended in 6 mL 1st antibiotic medium that have been
melted and cooled at 45 - 500C for 6 tubes, then shaken until
A
oiIT PI«115
CoacMieratioit (ppm) Si
h<
R1
Bo
D4
% L
»ÿ* * >
1/ * -
i
EM
homogeneous and poured above 2nd antibiotic medium, and
allowed to solidify. After the medium was solidified, then made
some holes in the agar medium, 50 pL of sample or standard
solution was poured into the hole. To obtain a calibration curve
concentrations were used GEN 0; 1.25; 2.5; 5.0; 10.0; 20.0, 40.0
ppm in sterile saline solution and also to know the MIC GEN
against Staphylococcus aureus. Samples were placed in differ¬
ent places in the petri dish and were incubated at room temper¬
ature for about 30 minutes. Then, the samples were incubated
at 370C. After 24 hours incubation, the diameter of inhibition intravenously or orally GEN administered. To prove that, the
agar diffusion method with Staphylococcus aureus were done
and the result showed in Figure 1. While the results of the
measurement of the inhibition zone diameter shown in Figure
2 for 28 days sampling. This suggests that GEN released dur¬
ing 28 days are stable and controlled with the concentrations
greater than 10 times the MIC GEN (0.4 ppm) against Staphy¬
lococcus aureus.
■
Figure 2. Inhibitor activity of GEN against Staphytococcu* atmits in Nutrient
Agar as sampling result of GEN release from BHAG(ELENA) pellet during
zone was measured (The experiment was done in triplo).
RESULT
Based on the observation result, some of GEN concentra¬
tions have a role as antibacterial It show from the amount of
inhibition zone diameter to the growth of Staphylococcus au¬
reus (ATCC 25923), it show at Figure 1.
The result of gentamicin (GEN) release from BHAG(ELE-
NA) pellet during 28 days immersion to the phosphate buffer
saline (PBS) show at Figure 3. And the release result that were
tested using agar diffusion method with Staphylococcus aureus
(ATCC 25923) show in Figure 2.
BHAG(ELENA) contain 891.463±44.203 pg and based on
Figure 3 show that the release of GEN from BHAG(ELENA)
for about 89.24% during 28 days. At the 28 days, the inhibi¬
tion zonediameter still greater than MIG This suggests that the
pellet was still actively releasing GEN to inhibit the growth of
Staphylococcus aureus.
DISCUSSION
Based on Figure 1, regression equation obtained y = Fl*ure 3- BHAG(ELENA) pdirt cumulative release GEN dunng 28 days(Sampling time vs Concentration of Released GEN)
§ -L-
i J
Sampling lima (Pay)
0.3194X + 12.7646 and R = 0.9528 (p< 0.05), this indicated that
if the GEN concentration increased it will increase the inhibi¬
tion zone diameter. The equation can be used as a reference to Based on Figure 3, show that the stady state concentration
calculate the concentration of GEN that release from the pellets of GEN (Css) = 41.47 ± 4. 19 ppm or 4.65% on day 2, which is
with plate method. Based on the activity test with turbidim- referred to as the stady state time (tss) GEN release from the
etry method, show that the minimal inhibitory concentration pellets. For the treatment of osteomyelitis (OM) takes a long
(MIC) of GEN against Staphylococcus aureus is 0.4 ppm, be- time is 4 to 6 weeks consisted of parenteral administration for 2
cause the MIC is not clear with plate method (<1.25 ppm).
Thus the release of GEN from BHAG(ELENA) pellets can Based on the result, need to do further testing in vivo of pellets
be controlled in the long term so that the bacteria can be eradi- BHAG (ELENA) by implantation in the femur of animals try
caled or controlled perfectly in areas difficult to reach with the practiced by Messeguer Olmoet al., (2002).
weeks and then continued orally 4 weeks (Dipiro et al., 2011).
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